In conclusion, the failure to demonstrate an effect of oxytocin in humans in relation to treatment of alcohol use disorder, despite the very promising results from rodent studies, may be due to problems with study designs or due to the extremely short half-life of oxytocin (5–30 min). The gene discussed is OXT; the disease is alcohol abuse.